Johann E Gudjonsson
Arthur C Curtis Professor of Skin Molecular Immunology
Professor of Dermatology
Professor of Internal Medicine and Research
Professor
Mary H Weiser Food Allergy
[email protected]

Available to mentor

Johann E Gudjonsson
Professor
  • About
  • Center Memberships
  • Recent Publications
  • About

    Dr. Johann Gudjonsson, MD, PhD is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. A graduate of the University of Iceland Medical School, he completed his internship and dermatology residency training at the University of Michigan. Dr. Gudjonsson has served on the faculty of the University of Michigan Department of Dermatology since 2008. He provides general medical dermatology patient care at the University of Michigan Taubman Center, and maintains clinical and research interests in inflammatory and autoimmune disorders involving the skin.

    Dr. Gudjonsson leads an NIH-funded research group examining the immunological and genetic drivers of inflammatory skin disease, with projects directed at improving the diagnosis and treatment of disorders, such as atopic dermatitis, cutaneous lupus, hidradenitis suppurativa, lichen planus, psoriasis and psoriatic arthritis.

    Dr. Gudjonsson's research has been supported by research awards from the National Institutes of Health (NIH), the American Skin Association, Dermatology Foundation, Doris Duke Foundation, among others. He is director of the U-M Skin Biology and Disease Resource-based Center which provides resources, training and support to new and early career investigators engaged in skin research and fosters interdisciplinary engagement and collaboration.

    Dr. Gudjonsson is a foremost expert in dermatological science, who received the 2007 Young Investigator Award from the American Academy of Dermatology, was named the 2018 Rising Star Lecturer for the Society for Investigative Dermatology and was recipient of the American Skin Association Research Achievement Award in Psoriasis in 2021. He serves as an Associate Editor for the Journal of Allergy and Clinical Immunology (JACI), and on the Editorial Board of JCI Insight. Dr. Gudjonsson is a standing member of the NIH Arthritis, Connective Tissue and Skin Study Section.

    Center Memberships
    • Center Member
      Taubman Institute
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    Recent Publications See All Publications
    • Chapter
      10 Genetics of Psoriasis
      Gudjonsson JE, Elder JT. 2025 Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics, 337 - 366. DOI:10.1016/b978-0-12-812531-1.00010-5
    • Journal Article
      Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens.
      Sampath AJ, Westerkam LL, Blum FR, Alhusayen R, Bechara FG, Caffrey J, Carmona-Rivera C, Chandran NS, George R, Goldberg SR, Gudjonsson JE, Hansen SL, Ingram JR, Kirby B, Marzano AV, Matusiak Ł, Orgill DP, Prens E, van der Zee HH, van Straalen KR, Zouboulis CC, Byrd AS, Frew JW, Lowes MA, Naik HB, Sokumbi O, Mi Q-S, Miedema JR, Googe PB, Sayed CJ. J Invest Dermatol, 2025 Jan; 145 (1): 50 - 55. DOI:10.1016/j.jid.2024.02.041
      PMID: 38901775
    • Journal Article
      Topical mupirocin treatment reduces interferon and myeloid signatures in cutaneous lupus erythematous lesions through targeting of Staphylococcus species.
      Abernathy-Close L, Mears J, Billi AC, Sirobhushanam S, Berthier C, Lu A, Zhang Z, Hurst A, Gudjonsson JE, Kahlenberg JM. Arthritis Rheumatol, 2024 Dec 8; DOI:10.1002/art.43079
      PMID: 39648343
    • Presentation
      Beyond clear skin: Demystifying the role IL-17A and IL-17F inhibition in psoriatic disease
      Gudjonsson J. 2024 Dec 6;
    • Presentation
      Modulation of the IL-23/IL-17 Axis Beyond IL-17A Drives Response to Risankizumab in Palmoplantar Psoriasis
      Gudjonsson J. 2024 Dec 6;
    • Presentation
      Lessons from transcriptomic, single-cell, and spatial analyses in psoriasis
      Gudjonsson J. 2024 Dec 3;
    • Presentation
      B cells and the BTK Pathway in Hidradenitis Suppurativa: Unraveling their Role in Pathogenesis and Decoding the Rationale for Therapeutic Targeting
      Gudjonsson J. 2024 Dec 2;
    • Journal Article
      004 Dietary fish oil eliminates skin inflammation via decreasing Serpinb3b and Slc25a5 and increasing Cacna2d1
      Gruszka D, Singh R, Tsoi LC, Gudjonsson JE, Ward NL. Journal of Investigative Dermatology, 2024 Dec; 144 (12): s229 DOI:10.1016/j.jid.2024.10.009
    Featured News & Stories
    Department News
    Dr. Johann Gudjonsson Named AAAS Fellow
    Dr. Johann Gudjonsson at the University of Michigan Named AAAS Fellow.